Neurocrine Biosciences, Inc.

This powerful committee controls taxation, trade, and entitlement spending (like Medicare). Its decisions on drug pricing within Medicare and corporate tax policy directly impact NBIX's profitability and market access for its products.

This committee allocates specific federal spending, directly determining funds for scientific research (e.g., NIH) and federal healthcare programs that may purchase or reimburse NBIX's products, thus impacting its revenue streams.

This committee directly regulates the FDA, which is responsible for drug approval – a fundamental process for NBIX's products. It also oversees NIH funding for research, directly impacting the biotech sector.

This committee's oversight of intellectual property (patents) is critical for pharmaceutical companies like NBIX. It also handles antitrust issues which can affect mergers and market practices within the industry.

Members receive classified briefings on global threats, including potential bioweapons or pandemics. Such information could create significant informational asymmetry for a biological product manufacturer like NBIX, especially if it relates to R&D or potential product relevance.